Pregabalin Completed Phase 1 Trials for Healthy Volunteers Screening

IndicationsStatusPurposePhase
CompletedScreening1
clinicaltrials.gov IdentifierTitleDrugs
NCT01420913Randomized, Open-label, Parallel Study to Evaluate the Pharmacokinetic Characteristics of Pregabalin According to Different Controlled Released Formulations in Healthy Male Subjects